Leissner P - Search Results

1

Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells.

Valsesia-Wittmann S, Magdeleine M, Dupasquier S, Garin E, Jallas AC, Combaret V, Krause A, Leissner P, Puisieux A. Valsesia-Wittmann S, et al. Among authors: leissner p. Cancer Cell. 2004 Dec;6(6):625-30. doi: 10.1016/j.ccr.2004.09.033. Cancer Cell. 2004. PMID: 15607966 Free article.

2

Genome-wide analysis of gene expression in neuroblastomas detected by mass screening.

Krause A, Combaret V, Iacono I, Lacroix B, Compagnon C, Bergeron C, Valsesia-Wittmann S, Leissner P, Mougin B, Puisieux A. Krause A, et al. Among authors: leissner p. Cancer Lett. 2005 Jul 8;225(1):111-20. doi: 10.1016/j.canlet.2004.10.035. Epub 2004 Dec 8. Cancer Lett. 2005. PMID: 15922863 Free article.

3

Prognostic significance of urokinase plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in lymph node- and hormone receptor-positive breast cancer.

Leissner P, Verjat T, Bachelot T, Paye M, Krause A, Puisieux A, Mougin B. Leissner P, et al. BMC Cancer. 2006 Aug 31;6:216. doi: 10.1186/1471-2407-6-216. BMC Cancer. 2006. PMID: 16945123 Free PMC article.

4

Multiparametric duplex real-time nucleic acid sequence-based amplification assay for mRNA profiling.

Verjat T, Cerrato E, Jacobs M, Leissner P, Mougin B. Verjat T, et al. Among authors: leissner p. Biotechniques. 2004 Sep;37(3):476-81. doi: 10.2144/04373PF01. Biotechniques. 2004. PMID: 15470903 Free article.

5

DNA nucleic acid sequence-based amplification-based genotyping for polymorphism analysis.

Berard C, Cazalis MA, Leissner P, Mougin B. Berard C, et al. Among authors: leissner p. Biotechniques. 2004 Oct;37(4):680-2, 684, 686. doi: 10.2144/04374DD04. Biotechniques. 2004. PMID: 15517981 Free article.

6

Longitudinal study of cytokine and immune transcription factor mRNA expression in septic shock.

Pachot A, Monneret G, Voirin N, Leissner P, Venet F, Bohé J, Payen D, Bienvenu J, Mougin B, Lepape A. Pachot A, et al. Among authors: leissner p. Clin Immunol. 2005 Jan;114(1):61-9. doi: 10.1016/j.clim.2004.08.015. Clin Immunol. 2005. PMID: 15596410

7

NASBA: a novel approach to assess hormonal receptors and ERBB2 status in breast cancer.

Lamy PJ, Verjat T, Paye M, Servanton AC, Grenier J, Leissner P, Mougin B. Lamy PJ, et al. Among authors: leissner p. Clin Chem Lab Med. 2006;44(1):3-12. doi: 10.1515/CCLM.2006.002. Clin Chem Lab Med. 2006. PMID: 16375577

8

Urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 mRNA assessment in breast cancer by means of NASBA: correlation with protein expression.

Lamy PJ, Verjat T, Servanton AC, Paye M, Leissner P, Mougin B. Lamy PJ, et al. Among authors: leissner p. Am J Clin Pathol. 2007 Sep;128(3):404-13. doi: 10.1309/K4JAF2NMD5EJU67Y. Am J Clin Pathol. 2007. PMID: 17709314

9

Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer.

Contreras-Galindo R, Kaplan MH, Leissner P, Verjat T, Ferlenghi I, Bagnoli F, Giusti F, Dosik MH, Hayes DF, Gitlin SD, Markovitz DM. Contreras-Galindo R, et al. Among authors: leissner p. J Virol. 2008 Oct;82(19):9329-36. doi: 10.1128/JVI.00646-08. Epub 2008 Jul 16. J Virol. 2008. PMID: 18632860 Free PMC article.

10

High-risk genotype for type 1 diabetes: a new simple microtiter plate-based ELOSA assay.

Geranton S, Rostagnat-Stefanutti A, Bendelac N, Cerrato E, Barbalat V, Leissner P, Nicolino M, Thivolet C, Mougin B. Geranton S, et al. Among authors: leissner p. Genet Test. 2003 Spring;7(1):7-12. doi: 10.1089/109065703321560877. Genet Test. 2003. PMID: 12820696

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters